Effectiveness of a booster dose of COVID-19 vaccines during an outbreak of SARS-CoV-2 Omicron BA.2.2 in China: A case–control study

Real-world evidence on the effectiveness of COVID-19 vaccines marketed in China against the Omicron BA.2.2 variant remains scarce. A case–control study was conducted to estimate the vaccine effectiveness (VE) of COVID-19 vaccines marketed in China (inactivated vaccines, an Ad5-nCoV vaccine, and a re...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaqing, Wang, Yao, Hu, Chengyang, Xu, Pengpeng, Ma, Liguo, Liu, Lei, Sun, Jie, Liu, Yang, Yang, Hui, Pan, Fan, Hu, Jieying, Cao, Chengsong, Cheng, Kai, Gao, Dawei, Lyu, Yong, Qin, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Coronavirus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088971/
https://www.ncbi.nlm.nih.gov/pubmed/36998173
http://dx.doi.org/10.1080/21645515.2023.2194189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088971/
https://www.ncbi.nlm.nih.gov/pubmed/36998173
http://dx.doi.org/10.1080/21645515.2023.2194189

Ejemplares similares